TrialLancet (London, England)2019

Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.

CRASH-3 trial collaboratorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.